1. Home
  2. RIV vs AMRN Comparison

RIV vs AMRN Comparison

Compare RIV & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIV
  • AMRN
  • Stock Information
  • Founded
  • RIV 2015
  • AMRN 1989
  • Country
  • RIV United States
  • AMRN Ireland
  • Employees
  • RIV N/A
  • AMRN N/A
  • Industry
  • RIV Finance Companies
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • RIV Finance
  • AMRN Health Care
  • Exchange
  • RIV Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • RIV 266.0M
  • AMRN 317.1M
  • IPO Year
  • RIV N/A
  • AMRN 1993
  • Fundamental
  • Price
  • RIV $12.45
  • AMRN $14.95
  • Analyst Decision
  • RIV
  • AMRN Strong Sell
  • Analyst Count
  • RIV 0
  • AMRN 1
  • Target Price
  • RIV N/A
  • AMRN $12.00
  • AVG Volume (30 Days)
  • RIV 87.6K
  • AMRN 62.0K
  • Earning Date
  • RIV 01-01-0001
  • AMRN 10-29-2025
  • Dividend Yield
  • RIV 12.85%
  • AMRN N/A
  • EPS Growth
  • RIV N/A
  • AMRN N/A
  • EPS
  • RIV N/A
  • AMRN N/A
  • Revenue
  • RIV N/A
  • AMRN $219,361,000.00
  • Revenue This Year
  • RIV N/A
  • AMRN N/A
  • Revenue Next Year
  • RIV N/A
  • AMRN N/A
  • P/E Ratio
  • RIV N/A
  • AMRN N/A
  • Revenue Growth
  • RIV N/A
  • AMRN N/A
  • 52 Week Low
  • RIV $9.63
  • AMRN $7.08
  • 52 Week High
  • RIV $12.43
  • AMRN $17.49
  • Technical
  • Relative Strength Index (RSI)
  • RIV 54.58
  • AMRN 43.50
  • Support Level
  • RIV $12.40
  • AMRN $14.64
  • Resistance Level
  • RIV $12.56
  • AMRN $15.45
  • Average True Range (ATR)
  • RIV 0.10
  • AMRN 0.48
  • MACD
  • RIV -0.00
  • AMRN -0.07
  • Stochastic Oscillator
  • RIV 52.73
  • AMRN 16.99

About RIV RiverNorth Opportunities Fund Inc.

Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: